BCL2L1 and breast carcinoma: c‐Myc drives the alternative splicing of genes MDM4 and Bcl‐x in breast cancer cells by transcriptionally upregulating serine/arginine‐rich splicing factor 10 (SRSF10), thereby accelerating breast cancer progression [188].